← Eichor
Study identifier: NCT06848166 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients With Chronic Resistant Migraine

Condition: Chronic Migraine Headache  ·  Sponsor: Vedanta University Clinic

PhaseEARLY_Phase 1
Planned participants30
Who can joinAll sexes, 35 Years to 59 Years
Healthy volunteersNo

About this study

To evaluate the effectiveness and safety of middle meningeal artery (MMA) embolization using non-adhesive materials SQUID 12 and SQUID 18 as a treatment method for patients with chronic resistant migraine.

This description comes directly from the study's public registry record.

Talk to the study team

Andrey E Petrov, MD, PhD  ·  +996 707 207 428  ·  doctorpetrovandrey@gmail.com

Andrey S Dakovskiy, MD  ·  +972532786627  ·  dakovskiyandrey@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Vedanta University ClinicBishkek, Bishkek, KyrgyzstanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06848166